Denali Therapeutics
DNLI
$20.51
Share price
1.33%
Change (1 day)
-31.04%
Change (1 year)
Market capitalization of Denali Therapeutics (DNLI)
Market cap: $2.92 Billion
As of May 2024 Denali Therapeutics has a market cap of $2.92 Billion. This makes Denali Therapeutics the world's 3549th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Denali Therapeutics from 2017 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.92 B | -1.38% |
| 2023 | $2.96 B | -21.48% |
| 2022 | $3.77 B | -30.66% |
| 2021 | $5.44 B | -45.77% |
| 2020 | $10.04 B | 499.44% |
| 2019 | $1.67 B | -14.32% |
| 2018 | $1.95 B | 42.13% |
| 2017 | $1.37 B |
End of Day market cap according to different sources
On May 17th, 2024 the market cap of Denali Therapeutics was reported to be:
$2.92 Billion
$2.92 Billion
$2.92 Billion
$2.92 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $11.77 M | -99.60% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.38 B | -87.00% | 🇬🇧 UK |
 Novavax NVAX | $1.91 B | -34.48% | 🇺🇸 USA |
 Novocure
NVCR | $2.36 B | -19.10% | Jersey |